It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months. A ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...